Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Hamilton

Showing results (401-410 of 425) with videos related to

Pageof 43
Sort By:
Inquiry : a Journal of Medical Care Organization, Provision and Financing|August 28, 1998
Case study: The Washington State Health Care AuthorityV M Wilson, C A Smith, J M Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I clinical trial of continuous infusion cyclopentenyl cytosineP M Politi, F Xie, W Dahut, et al.
Cancer Research|October 15, 1993
A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, S M Steinberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumorsS N Khleif, S I Abrams, J M Hamilton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinomaJ L Grem, L K Yee, B Schuler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
High inter- and intrapatient variation in 5-fluorouracil plasma concentrations during a prolonged drug infusionC H Takimoto, L K Yee, D J Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancerK S Bauer, W D Figg, J M Hamilton, et al.
European Journal of Clinical Nutrition|March 16, 2007
Probiotic capsules do not lower plasma lipids in young women and menK A Greany, M J L Bonorden, J M Hamilton-Reeves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinomaJ L Grem, N McAtee, R F Murphy, et al.
Pageof 43

Showing results (401-410 of 425) with videos related to

Sort By:
Pageof 43
Inquiry : a Journal of Medical Care Organization, Provision and Financing|August 28, 1998
Case study: The Washington State Health Care AuthorityV M Wilson, C A Smith, J M Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I clinical trial of continuous infusion cyclopentenyl cytosineP M Politi, F Xie, W Dahut, et al.
Cancer Research|October 15, 1993
A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, S M Steinberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumorsS N Khleif, S I Abrams, J M Hamilton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinomaJ L Grem, L K Yee, B Schuler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
High inter- and intrapatient variation in 5-fluorouracil plasma concentrations during a prolonged drug infusionC H Takimoto, L K Yee, D J Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancerK S Bauer, W D Figg, J M Hamilton, et al.
European Journal of Clinical Nutrition|March 16, 2007
Probiotic capsules do not lower plasma lipids in young women and menK A Greany, M J L Bonorden, J M Hamilton-Reeves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinomaJ L Grem, N McAtee, R F Murphy, et al.
Pageof 43